These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1601636)

  • 1. Acute intermittent porphyria. A perplexing case.
    Arena A; Russo P; Scuderi D
    Ital J Neurol Sci; 1992 May; 13(4):357-9. PubMed ID: 1601636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurologic disorders in acute intermittent porphyria].
    Niewiadomska M; Wochnik-Dyjas D; Kostrzewska E; Gregor A
    Neurol Neurochir Pol; 1978; 12(3):219-27. PubMed ID: 683426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Guide and Update on Porphyrias.
    Stölzel U; Doss MO; Schuppan D
    Gastroenterology; 2019 Aug; 157(2):365-381.e4. PubMed ID: 31085196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute intermittent porphyria.
    Day RS; Eales L
    S Afr Med J; 1982 Feb; 61(8):260-1. PubMed ID: 7058452
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative effects of glycerol and dextrose on porphyrin precursor excretion in acute intermittent porphyria.
    Bonkowsky HL; Magnussen CR; Collins AR; Doherty JM; Hess RA; Tschudy DP
    Metabolism; 1976 Apr; 25(4):405-14. PubMed ID: 1263834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manifestation of acute intermittent porphyria in patients with chronic inflammatory bowel disease.
    Sieg I; Beckh K; Kersten U; Doss MO
    Z Gastroenterol; 1991 Nov; 29(11):602-5. PubMed ID: 1771936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An acute attack of variegate porphyria complicated by severe autonomic neuropathy.
    Stewart PM; Hensley WJ
    Aust N Z J Med; 1981 Feb; 11(1):82-3. PubMed ID: 6941785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of porphyrins, porphobilinogen and δ-aminolaevulinic acid following an attack of acute intermittent porphyria.
    Marsden JT; Rees DC
    J Clin Pathol; 2014 Jan; 67(1):60-5. PubMed ID: 23908454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A LC-MS/MS method for the specific, sensitive, and simultaneous quantification of 5-aminolevulinic acid and porphobilinogen.
    Zhang J; Yasuda M; Desnick RJ; Balwani M; Bishop D; Yu C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(24):2389-96. PubMed ID: 21783436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of 3-ethyl-5-hydroxy-4,5-dimethyl-delta 3-pyrrolin-2-one in the urine of patients with acute intermittent porphyria.
    Graham DJ; Brodie MJ; McColl KE; Moore MR; Goldberg A
    Eur J Clin Invest; 1979 Feb; 9(1):49-53. PubMed ID: 110600
    [No Abstract]   [Full Text] [Related]  

  • 11. Intermittent acute porphyria.
    Arch Intern Med; 1982 Aug; 142(8):1527-9. PubMed ID: 7103634
    [No Abstract]   [Full Text] [Related]  

  • 12. Estimation and application of biological variation of urinary delta-aminolevulinic acid and porphobilinogen in healthy individuals and in patients with acute intermittent porphyria.
    Aarsand AK; Petersen PH; Sandberg S
    Clin Chem; 2006 Apr; 52(4):650-6. PubMed ID: 16595824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria.
    Balwani M; Sardh E; Ventura P; Peiró PA; Rees DC; Stölzel U; Bissell DM; Bonkovsky HL; Windyga J; Anderson KE; Parker C; Silver SM; Keel SB; Wang JD; Stein PE; Harper P; Vassiliou D; Wang B; Phillips J; Ivanova A; Langendonk JG; Kauppinen R; Minder E; Horie Y; Penz C; Chen J; Liu S; Ko JJ; Sweetser MT; Garg P; Vaishnaw A; Kim JB; Simon AR; Gouya L;
    N Engl J Med; 2020 Jun; 382(24):2289-2301. PubMed ID: 32521132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in porphobilinogen and 5-aminolevulinic acid concentrations in plasma and urine from asymptomatic carriers of the acute intermittent porphyria gene with increased porphyrin precursor excretion.
    Floderus Y; Sardh E; Möller C; Andersson C; Rejkjaer L; Andersson DE; Harper P
    Clin Chem; 2006 Apr; 52(4):701-7. PubMed ID: 16497943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What is your diagnosis? Acute intermittent porphyria].
    Marty H
    Schweiz Rundsch Med Prax; 1992 Dec; 81(49):1471-2. PubMed ID: 1462067
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pathophysiology and diagnosis of acute intermittent porphyria].
    Wichmann T; Freye HA
    Z Gesamte Inn Med; 1977 Jun; 32(12):289-92. PubMed ID: 910533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urinary excretion of porphyrins and their precursors. Longterm observations in acute intermittent porphyrias (author's transl)].
    Brugsch J; Müller H
    MMW Munch Med Wochenschr; 1979 Mar; 121(13):457-8. PubMed ID: 107424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic prognosis of a mother with acute intermittent porphyria (hepatic form)].
    Pfändler U
    J Genet Hum; 1974 Jun; 22(2):185-7. PubMed ID: 4420375
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of transcutaneous nerve stimulation in the attacks of acute intermittent porphyria.
    Kaada B; Romslo I
    Int J Biochem; 1985; 17(2):235-40. PubMed ID: 3874101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic and therapeutic problems in acute intermittent porphyria].
    Mühler E
    Nervenarzt; 1976 Feb; 47(2):126-9. PubMed ID: 1256621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.